{
    "clinical_study": {
        "@rank": "80882", 
        "arm_group": [
            {
                "arm_group_label": "1", 
                "arm_group_type": "Experimental", 
                "description": "Transdermal nicotine plus nortriptyline"
            }, 
            {
                "arm_group_label": "2", 
                "arm_group_type": "Active Comparator", 
                "description": "Transdermal nicotine plus placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "Treatment of smokers with a tricyclic antidepressant, nortriptyline, can reduce tobacco\n      withdrawal symptoms and increases long term cessation rates when combined with transdermal\n      nicotine and a behavioral cessation programs.  The study is a placebo-controlled,\n      randomized, parallel group trial in which smokers aged 18-70 will be subject to the\n      combination of oral and patch treatments."
        }, 
        "brief_title": "Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation", 
        "completion_date": {
            "#text": "January 2003", 
            "@type": "Actual"
        }, 
        "condition": "Smoking", 
        "condition_browse": {
            "mesh_term": "Smoking"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged 18-70,\n\n          -  smoking > 10 cigarettes per day,\n\n          -  no current major depression,\n\n          -  no concurrent psychiatric medications\n\n        Exclusion Criteria:"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "158", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 3, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00018148", 
            "org_study_id": "ADRD-006-97F"
        }, 
        "intervention": [
            {
                "arm_group_label": "1", 
                "description": "Dose titrated to 75 mg daily as tolerated combined with transdermal nicotine 21 mg", 
                "intervention_name": "nortriptyline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "2", 
                "description": "Transdermal nicotine 21 mg, titrated down plus placebo", 
                "intervention_name": "transdermal nicotine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex", 
                "Nortriptyline"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "smoking cessation", 
        "lastchanged_date": "September 14, 2010", 
        "location": {
            "facility": {
                "address": {
                    "city": "Denver", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80220"
                }, 
                "name": "VA Eastern Colorado Health Care System, Denver"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation", 
        "overall_official": {
            "affiliation": "VA Eastern Colorado Health Care System, Denver", 
            "last_name": "Allan V. Prochazka, MD MSc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2002", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Validated smoking cessation", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00018148"
        }, 
        "responsible_party": {
            "name_title": "Prochazka, Allan - Principal Investigator", 
            "organization": "Department of Veterans Affairs"
        }, 
        "results_reference": {
            "PMID": "15534159", 
            "citation": "Prochazka AV, Kick S, Steinbrunn C, Miyoshi T, Fryer GE. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. Arch Intern Med. 2004 Nov 8;164(20):2229-33."
        }, 
        "source": "Department of Veterans Affairs", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Department of Veterans Affairs", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "April 1998", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2010"
    }, 
    "geocoordinates": {
        "VA Eastern Colorado Health Care System, Denver": "39.739 -104.985"
    }
}